Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Fatty amides [FA08]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA08020271 N-linolenoyl dopamine N-(9Z,12Z,15Z-octadecatrienoyl) dopamine NA 26:7;O2 C26H39NO3 413.292994
LMFA08020272 Dihomo-gamma-linolenoyl dopamine N-(8Z,11Z,14Z-eicosatrienoyl) dopamine NA 28:7;O2 C28H43NO3 441.324294
LMFA08020273 N-gamma-linolenoyl dopamine N-(6Z,9Z,12Z-octadecatrienoyl) dopamine NA 26:7;O2 C26H39NO3 413.292994
LMFA08020274 N-(7Z,10Z,13Z-16Z-docosatetraenoyl) dopamine N-(7Z,10Z,13Z-16Z-docosatetraenoyl) dopamine NA 30:8;O2 C30H45NO3 467.339944
LMFA08040059 Vaccenoyl-EA N-(11Z-octadecenoyl)- ethanolamine NAE 18:1 C20H39NO2 325.298079
LMFA08040060 Elaidoyl-EA N-(9E-octadecenoyl)-ethanolamine NAE 18:1 C20H39NO2 325.298079
LMFA08040061 trans-vaccenoyl-EA N-(11E-octadecenoyl)-ethanolamine NAE 18:1 C20H39NO2 325.298079
LMFA08040062 Petroselaidoyl-EA N-(6E-octadecenoyl)-ethanolamine NAE 18:1 C20H39NO2 325.298079
LMFA08040063 Bishomostearidonoyl-EA N-(8Z,11Z,14Z,17Z-eicoscatetraenoyl)-ethanolamine NAE 20:4 C22H37NO2 347.282429
LMFA08040064 Juniperonoyl-EA N-(5Z,11Z,14Z,17Z-eicosatetraenoyl)-ethanolamine NAE 20:4 C22H37NO2 347.282429
LMFA08040065 Sciadonoyl-EA N-(5Z,11Z,14Z-eicosatrienoyl)-ethanolamine NAE 20:3 C22H39NO2 349.298079
LMFA08020261 N-lauroyl glycine N-dodecanoyl glycine NAGly 12:0 C14H27NO3 257.199094
LMFA08020262 N-lauroyl lysine N-dodecanoyl lysine NALys 12:0 C18H36N2O3 328.272593
LMFA08020263 N-physeteroyl lysine N-(5Z-tetradecenoyl) lysine NALys 14:1 C20H38N2O3 354.288243
LMFA08020260 N-arachidonoyl alanine N-(5Z,8Z,11Z,14Z-eicosatetraenoyl) alanine NAAla 20:4 C23H37NO3 375.277344
LMFA08020264 N-myristoyl lysine N-tetradecanoyl lysine NALys 14:0 C20H40N2O3 356.303893
LMFA08020275 alpha-N-(3-hexadecanoyloxy-hexadecanoyl)-L-ornithine (2S)-5-amino-2-(3-hexadecanoyloxy-hexadecanamido)pentanoic acid C37H72N2O5 624.544123
LMFA08040066 Semiplenamide A N-(2-methyl-2Z,6E-eicosadienoyl)-ethanolamine NAE 21:2 C23H43NO2 365.329379
LMFA08020276 Semiplenamide B N-(2-methyl-2Z,6E-eicosadienoyl)-2-acetoxyethylamine NA 25:3;O2 C25H45NO3 407.339944
LMFA08020277 Semiplenamide C N-(2-methyl-2Z-hexadecenoyl)-1-hydroxypropyl-2(S)-amine NA 20:1;O C20H39NO2 325.298079
LMFA08020278 Semiplenamide D N-(2-methyl-2Z-eicosenoyl)-1S-methyl-2-acetoxyethylamine NA 26:2;O2 C26H49NO3 423.371244
LMFA08020279 Semiplenamide E N-(2-methyl-2Z-octadecenoyl)-1S-methyl-2-acetoxyethylamine NA 24:2;O2 C24H45NO3 395.339944
LMFA08020280 Semiplenamide G N-(2-methyl-2S,3R-epoxy-octadecanoyl)-1-methyl-2-acetoxyethylamine NA 24:2;O3 C24H45NO4 411.334859
LMFA08020281 Semiplenamide F N-(2-methyl-2S,3R-epoxy-octadecanoyl)-1-hydroxypropyl-2-amine NA 22:1;O2 C22H43NO3 369.324294
LMFA08020282 Granadaene (2S)-5-amino-2-(27R-O-alpha-L-rhamnopyranosyl-2E,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E,24E-octacosadodecaenoyl)pentanoic acid C39H52N2O8 676.372368
LMFA08040067 Tetracosahexaenoyl-EA N-(6Z,9Z,12Z,15Z,18Z,21Z-tetracosahexaenoyl)-ethanolamine NAE 24:6 C26H41NO2 399.313729
LMFA08020283 N-3-hydroxy-13-methyl-hexadecanoyl glycyl-L-serine C22H42N2O6 430.304288
LMFA08020284 Topostin B553 N-(3R-(13-methyl-tetradecanoyloxy)-hexadecanoyl)-glycine C33H63NO5 553.470624
LMFA08020285 Topostin D654 N-(15-methyl-3R-(13-methyl-tetradecanoyloxy)-hexadecanoyl)-glycylserine C37H70N2O7 654.518303
LMFA08020286 Topostin D654 N-(3R-(13-methyl-tetradecanoyloxy)-hexadecanoyl)-glycylserine C36H68N2O7 640.502653
LMFA08020287 N-(14-methyl-3S-(13-methyl-4Z-tetradecenoyloxy)-pentadecanoyl)-glycine NA 33:3;O4 C33H61NO5 551.454974
LMFA08010029 Bacillamidin F 14-methyl-pentadecamide C16H33NO 255.256214
LMFA08010030 Bacillamidin G 15-methyl-heptadecamide C18H37NO 283.287514
LMFA08020288 Bacillamidin A N-(9-methyldecanoyl)-dimethyaspartate NA 17:2;O4 C17H31NO5 329.220224
LMFA08020289 Bacillamidin B N-(10-methyldodecanoyl)-dimethyaspartate NA 19:2;O4 C19H35NO5 357.251524
LMFA08020290 Bacillamidin D N-[(3R)-1-(2-methylpropyl)-2,5-dioxopyrrolidin-3-yl]-9-methyldecanamide C19H34N2O3 338.256943
LMFA08020291 Bacillamidin C N-[(3R)-2,5-dioxopyrrolidin-3-yl]-10-methyldodecanamide C17H30N2O3 310.225643
LMFA08020292 Bacillamidin E N-[(2S,3S)-2-[(1S)-1-hydroxy-2-[[(1S)-1-[(3S)-8-hydroxy-1-oxo-3,4-dihydroisochromen-3-yl]-3-methylbutyl]amino]-2-oxoethyl]-5-oxooxolan-3-yl]-13-methyltetradecanamide C36H56N2O7 628.408753
LMFA08030040 N-(2E,9Z-hexadecadienoyl)-homoserine lactone N-(2E,9Z-hexadecadienoyl)-homoserine lactone C20H33NO3 335.246044
LMFA08030041 N-(7-methyloctanoyl)homoserine lactone N-(7-methyloctanoyl)homoserine lactone C13H23NO3 241.167794
LMFA08030042 N-(3-hydroxy-7-methyloctanoyl)homoserine lactone N-(3-hydroxy-7-methyloctanoyl)homoserine lactone C13H23NO4 257.162709
LMFA08020297 Mutanamide N-(3-oxo-decanoyloxy)-L-leucyl-L-alanine C19H34N2O5 370.246773
LMFA08020298 1-tauro-dinor-PGE1 N-tauro-9,13-dihydroxy-7-oxo-dinorprosta-11-enoate NAT 18:3;O3 C20H35NO7S 433.213426
LMFA08020299 1-tauro-tetranor-PGE1 N-tauro-9,13-dihydroxy-7-oxo-tetranorprosta-11-enoate NAT 16:3;O3 C18H31NO7S 405.182126
LMFA08020300 1-tauro-dinor-PGE2 N-tauro-9,13-dihydroxy-7-oxo-dinorprosta-3Z,11E-dienoate NAT 18:4;O3 C20H33NO7S 431.197776
LMFA08020301 1-tauro-PGE2 N-tauro-9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoate NAT 20:4;O3 C22H37NO7S 459.229076
LMFA08030043 N-isovaleryl-homoserine lactone N-(4-methyl-butanoyl)-l-homoserine lactone C9H15NO3 185.105194
LMFA08030044 p-coumaroyl-homoserine lactone N-(4-coumaroyl)-L-homoserine lactone C13H13NO4 247.084459
LMFA08030045 Cinnamoyl-homoserine lactone N-Cinnamoyl-L-homoserine lactone C13H13NO3 231.089544
LMFA08030046 N-(2E-dodecenoyl)-homoserine lactone N-(2E-dodecenoyl)-homoserine lactone C16H27NO3 281.199094